Search





Search





Markets
/
Stocks
/
ctxr
/

Citius Pharmaceuticals Inc

CTXR

Add to Watchlist

0.505USD

-0.012-2.24%

Close 07-28 16:00（ET）Quotes delayed by 15 min

7.31MMarket Cap

LossP/E TTM

Citius Pharmaceuticals Inc

0.505

-0.012-2.24%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

CTXR Cash Flow Statement

You can access the annual and quarterly cash flow statements of Citius Pharmaceuticals Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q3

FY2017Q2

FY2017Q1

FY2016Q3

FY2016Q2

FY2016Q1

FY2015Q3

FY2015Q2

FY2015Q1

FY2014Q3

FY2014Q2

FY2014Q1

FY2013Q3

FY2013Q2

FY2013Q1

FY2012Q4

FY2012Q3

FY2012Q2

FY2012Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

71.36%-1.30M

-175.27%-13.01M

-100.94%-11.88M

35.38%-5.41M

41.70%-4.54M

22.97%-4.73M

13.05%-5.91M

12.68%-8.37M

0.85%-7.79M

-27.17%-6.14M

-7.39%-6.80M

-24.25%-9.58M

18.75%-7.85M

-3.72%-4.82M

---6.33M

-59.88%-7.71M

-126.28%-9.67M

51.37%-4.65M

-20.86%-4.82M

4.39%-4.27M

-87.02%-9.56M

-13.31%-3.99M

-16.05%-4.47M

-136.93%-5.11M

-56.82%-3.52M

6.71%-3.85M

11.57%-2.16M

6.51%-2.25M

-400.41%-4.13M

-85.66%-2.44M

6.22%-2.40M

5.70%-824.60K

-88.61%-1.31M

-307.68%-2.56M

-175.96%-874.45K

5.14%-697.09K

-12495.93%-628.41K

-8995.35%-316.88K

-40.80%-734.82K

-54.17%-4.99K

64.22%-3.48K

-221036.44%-521.88K

45.90%-3.24K

-45.34%-9.74K

89.25%-236.00

---5.45K

---5.98K

---6.70K

---2.20K

Net income from continuing operations

-144.19%-28.11M

8.63%-9.39M

21.07%-8.74M

12.95%-9.20M

-34.73%-11.51M

-11.38%-10.28M

-11.40%-11.08M

-24.70%-10.57M

18.83%-8.54M

-156.88%-9.23M

-24.44%-9.94M

4.34%-8.48M

-39.21%-10.53M

61.05%-3.59M

---7.99M

-52.19%-8.86M

-83.41%-7.56M

-13.24%-9.23M

-24.44%-5.82M

6.84%-4.12M

-88.48%-8.15M

-6.23%-4.68M

-21.84%-4.42M

-11.55%-4.32M

-117.89%-4.41M

17.86%-3.63M

-19.36%-3.87M

16.53%-2.02M

-61.18%-4.42M

-49.19%-3.25M

33.01%-2.42M

-215.53%-2.74M

-78.25%-2.18M

-338.31%-3.62M

-151.82%-869.45K

-48.20%-1.22M

-13001.03%-824.97K

-3350.95%-345.27K

-54.13%-823.71K

-42.08%-6.30K

2.19%-10.01K

-37534.79%-534.41K

35.17%-4.43K

-41.87%-10.23K

44.70%-1.42K

---5.39K

---6.84K

---7.21K

---2.57K

Operating gains losses

----

14942.55%41.37K

9573.58%56.01K

-100.00%0.00

-56.28%275.00

-20.79%579.00

-20.82%578.00

-20.93%578.00

-13.95%629.00

0.00%731.00

0.00%730.00

--731.00

60.31%731.00

380.92%731.00

377.12%730.00

64.03%456.00

-14.12%152.00

-13.56%153.00

17.80%278.00

-24.68%177.00

0.43%236.00

-63.34%235.00

-63.40%235.00

-65.03%235.00

-4.47%641.00

-4.46%642.00

0.15%672.00

--671.00

--672.00

--671.00

----

Deferred tax

-187.50%-231.21K

0.00%264.24K

83.50%264.24K

0.00%144.00K

-75.00%144.00K

--144.00K

--576.00K

----

Other non-cash items

3044.03%1.76M

1236.85%733.06K

65.10%88.64K

-74.55%41.37K

-62.55%56.01K

-56.68%54.84K

8.70%53.69K

235.87%162.52K

0.11%149.57K

172.46%126.58K

-67.04%49.39K

8.45%48.39K

-32.62%149.41K

-66.52%46.46K

--149.84K

8.22%44.62K

104.48%221.74K

249.78%138.76K

-22.95%41.23K

-69.31%108.44K

-70.52%39.67K

--53.51K

200.68%353.30K

--134.57K

-100.00%0.00

132.53%117.50K

-100.00%0.00

-92.59%31.00K

-220.89%-361.20K

--257.40K

7643.97%418.25K

231.97%298.77K

----

--5.40K

--90.00K

----

--0.00

-100.00%0.00

----

--10.50K

----

Change in working capital

444.13%21.49M

-427.95%-8.89M

-374.35%-6.38M

166.40%771.97K

251.08%3.95M

1261.42%2.71M

1942.79%2.33M

52.94%-1.16M

-315.48%-2.61M

91.10%-233.46K

-180.37%-126.19K

-2508.46%-2.47M

136.24%1.21M

-174.32%-2.62M

---45.01K

-82.47%102.57K

-457.55%-3.35M

303.54%3.53M

27.14%585.25K

-8.19%-600.42K

-51.18%-1.73M

-32.21%460.32K

-2.94%-554.95K

-174.25%-1.15M

278.78%679.00K

-222.21%-539.09K

501.01%1.54M

52.48%-379.80K

-61.29%441.13K

-79.29%257.02K

-11.22%-799.25K

378.97%1.14M

191.15%1.24M

-3778.85%-718.63K

-323.42%-408.46K

949.68%426.28K

-1516.44%-18.53K

2703.56%182.82K

1898.52%40.61K

9.36%1.31K

1222.72%6.52K

71.62%2.03K

39.88%1.20K

-3.52%493.00

218.28%1.18K

---56.00

--855.00

--511.00

--372.00

-Change in receivables

--2.97M

---4.05M

----

--0.00

-100.00%0.00

--0.00

--818.34K

----

-Change in inventory

97.89%-20.25K

94.23%-352.65K

-73.82%-3.71M

---1.87M

---957.88K

---6.11M

---2.13M

----

-Change in prepaid expenses

209.42%178.41K

-1368.24%-2.14M

-215.19%-1.45M

256.93%1.70M

85.82%-163.05K

-682.72%-145.74K

2302.82%1.26M

45.89%-1.08M

-183.52%-1.15M

100.97%25.01K

8.15%-57.19K

-595.21%-2.00M

-2083.45%-405.48K

-1283.16%-2.58M

---62.26K

-5197.80%-287.21K

225.84%20.44K

118.76%217.85K

170.61%5.63K

201.20%6.27K

-15105.16%-1.16M

-3.92%2.08K

--2.08K

-168.74%-7.64K

126.00%2.17K

-100.00%0.00

-89.85%11.11K

-107.05%-8.33K

-71.48%46.02K

-29.38%109.43K

131.61%118.19K

168.98%161.39K

--154.96K

-6217.74%-373.88K

--60.00K

----

---5.92K

----

100.00%0.00

----

--5.95K

---9.17K

----

-Change in other current assets

----

--0.00

-100.00%0.00

--0.00

--19.03K

----

-Change in other current liabilities

----

--0.00

100.00%0.00

--0.00

---17.64K

---10.00K

100.00%0.00

----

-41.71%-30.97K

-105.76%-1.77K

----

---21.86K

--30.81K

-100.00%0.00

----

--701.00

----

Cash from non-recurring investing activities

Cash from operating activities

71.36%-1.30M

-175.27%-13.01M

-100.94%-11.88M

35.38%-5.41M

41.70%-4.54M

22.97%-4.73M

13.05%-5.91M

12.68%-8.37M

0.85%-7.79M

-27.17%-6.14M

-7.39%-6.80M

-24.25%-9.58M

18.75%-7.85M

-3.72%-4.82M

---6.33M

-59.88%-7.71M

-126.28%-9.67M

51.37%-4.65M

-20.86%-4.82M

4.39%-4.27M

-87.02%-9.56M

-13.31%-3.99M

-16.05%-4.47M

-136.93%-5.11M

-56.82%-3.52M

6.71%-3.85M

11.57%-2.16M

6.51%-2.25M

-400.41%-4.13M

-85.66%-2.44M

6.22%-2.40M

5.70%-824.60K

-88.61%-1.31M

-307.68%-2.56M

-175.96%-874.45K

5.14%-697.09K

-12495.93%-628.41K

-8995.35%-316.88K

-40.80%-734.82K

-54.17%-4.99K

64.22%-3.48K

-221036.44%-521.88K

45.90%-3.24K

-45.34%-9.74K

89.25%-236.00

---5.45K

---5.98K

---6.70K

---2.20K

Investing cash flow

Net cash from continuing investing activities

--600.00K

--4.40M

15.00%5.75M

----

--5.00M

----

--0.00

----

278.92%6.94K

----

--1.83K

----

Capital expenditures

--600.00K

--4.40M

15.00%5.75M

----

--5.00M

----

--0.00

----

278.92%6.94K

----

--1.83K

----

Net cash flow from disposal of fixed assets

----

--0.00

----

278.92%6.94K

----

--1.83K

----

Net cash flow from intangible asset transactions

--600.00K

--4.40M

15.00%5.75M

----

--5.00M

----

Net cash flow from business transactions

----

--0.00

-100.00%0.00

----

--0.00

--255.75K

----

Net cash flow from other investing activities

--0.00

----

--0.00

----

--0.00

Cash from non-current investing activities

Net cash flow from investing activities

---600.00K

---4.40M

-15.00%-5.75M

----

---5.00M

----

--0.00

----

-278.92%-6.94K

----

---1.83K

----

--0.00

-100.00%0.00

----

--0.00

--255.75K

----

--0.00

----

--0.00

Financing cash flow

Cash flow from continuous financing activities

-135.52%-1.23M

711.09%20.88M

521.55%15.79M

-16.40%11.47M

--3.47M

--2.57M

-545260.12%-3.75M

-0.58%13.72M

----

---687.00

--13.80M

--31.27K

--0.00

-100.00%0.00

105.57%16.80M

1620.13%103.67M

371.70%500.00

69.03%8.17M

83423.16%6.03M

-99.34%106.00

--4.83M

-99.59%7.22K

-99.76%16.00K

-100.00%0.00

110.21%1.76M

519.16%6.61M

492.08%2.54M

-79.52%838.95K

252.87%1.07M

-47.62%429.00K

1475.48%4.10M

--302.44K

16317.18%819.05K

7362.69%260.00K

-100.00%0.00

55.91%4.99K

-64.08%3.48K

287400.00%575.00K

-47.84%3.20K

49.23%9.70K

-90.91%200.00

--5.41K

--6.13K

--6.50K

--2.20K

Net cash flow from debt Issuance/repayment

---1.00M

----

--0.00

--1.00M

----

--0.00

----

--0.00

-100.00%0.00

-205.10%-172.97K

--0.00

--500.00

--164.58K

----

-100.00%0.00

----

526.67%2.56M

--530.00K

--820.00K

---600.00K

----

-100.00%0.00

55.91%4.99K

-64.08%3.48K

299900.00%600.00K

-47.84%3.20K

49.23%9.70K

-90.91%200.00

--5.41K

--6.13K

--6.50K

--2.20K

Net cash flow from common stock issuance/repurchase

-101.81%-62.76K

711.09%20.88M

18539.67%15.79M

-23.69%10.47M

--3.47M

--2.57M

--84.73K

-0.58%13.72M

----

--13.80M

----

--0.00

----

-100.00%0.00

--70.98M

----

42.27%6.88M

----

--4.83M

-100.00%0.00

--0.00

--1.76M

--5.48M

----

--0.00

----

--0.00

----

Net cash flow from preferred stock issuance/repurchase

----

--0.00

----

Proceeds from stock option exercised by employees

----

--0.00

--31.27K

----

--82.63K

----

--40.00

----

Proceeds from issuance of warrants

--818.00

----

--0.00

-100.00%0.00

----

1395.26%16.89M

136.31%14.24M

-100.00%0.00

--1.13M

83423.16%6.03M

-99.34%106.00

--0.00

--7.22K

-98.58%16.00K

--0.00

--1.13M

----

Net cash flow from other financing activities

---169.25K

--0.00

100.00%0.00

----

---3.83M

----

--0.00

----

--0.00

--18.45M

----

100.00%0.00

----

-101.94%-20.00K

-92.46%308.95K

-18.26%247.21K

25.63%1.03M

1475.48%4.10M

--302.44K

--819.05K

--260.00K

100.00%0.00

----

---25.00K

----

Net cash from non-recurrent financing activities

Net cash from financing activities

-135.52%-1.23M

711.09%20.88M

521.55%15.79M

-16.40%11.47M

--3.47M

--2.57M

-545260.12%-3.75M

-0.58%13.72M

----

---687.00

--13.80M

--31.27K

--0.00

-100.00%0.00

105.57%16.80M

1620.13%103.67M

371.70%500.00

69.03%8.17M

83423.16%6.03M

-99.34%106.00

--4.83M

-99.59%7.22K

-99.76%16.00K

-100.00%0.00

110.21%1.76M

519.16%6.61M

492.08%2.54M

-79.52%838.95K

252.87%1.07M

-47.62%429.00K

1475.48%4.10M

--302.44K

16317.18%819.05K

7362.69%260.00K

-100.00%0.00

55.91%4.99K

-64.08%3.48K

287400.00%575.00K

-47.84%3.20K

49.23%9.70K

-90.91%200.00

--5.41K

--6.13K

--6.50K

--2.20K

Net cash flow

Beginning cash balance

601.89%7.72M

30.76%4.25M

-66.00%6.09M

-99.79%26.41K

-94.59%1.10M

-87.72%3.25M

-46.18%17.91M

-56.79%12.56M

-44.84%20.35M

-36.51%26.48M

-30.73%33.28M

-47.87%29.07M

-43.62%36.89M

-40.47%41.71M

--48.04M

-46.23%55.76M

1422.96%65.42M

405.59%70.07M

2289.85%103.70M

54.54%4.30M

75.58%13.86M

35.63%4.34M

-60.52%2.78M

-14.05%7.89M

-36.12%3.20M

-4.47%7.04M

186.63%9.18M

8094.84%5.01M

15661.48%7.37M

988.53%3.20M

-98.37%61.11K

-83.39%46.76K

-56.47%294.35K

394.38%3.76M

-65.56%281.49K

-56.44%676.14K

--760.36K

--817.24K

121917.30%1.55M

-100.00%0.00

842.22%1.27K

270.59%63.00

-54.17%99.00

-36.32%135.00

--171.00

--17.00

--216.00

--212.00

Current period cash flow changes

-191.64%-3.13M

261.22%3.47M

87.47%-1.84M

13.29%6.06M

86.21%-1.07M

64.93%-2.15M

-115.55%-14.66M

26.93%5.35M

0.46%-7.79M

-27.17%-6.14M

-7.40%-6.80M

154.67%4.22M

19.07%-7.82M

-3.72%-4.82M

---6.33M

-164.45%-7.71M

-109.72%-9.67M

51.36%-4.65M

186.41%11.97M

6274.25%99.40M

-87.01%-9.56M

218.55%4.18M

140.58%1.56M

-138.70%-5.11M

158.40%1.31M

-62.62%-3.84M

-151.42%-2.14M

-1732.10%-2.25M

-16570.32%-2.36M

1782.88%4.17M

106.45%137.62K

-99.59%14.35K

37.26%-247.59K

-1218.80%-2.13M

6213.61%3.48M

46.29%-394.65K

--190.64K

---56.88K

-1483.38%-734.82K

100.00%0.00

147650.00%53.12K

-123.38%-36.00

81.91%-36.00

-1000.00%-36.00

---36.00

--154.00

---199.00

--4.00

Ending cash balance

17280.44%4.59M

601.89%7.72M

30.76%4.25M

-66.00%6.09M

-99.79%26.41K

-94.59%1.10M

-87.72%3.25M

-46.18%17.91M

-56.79%12.56M

-44.84%20.35M

-36.51%26.48M

-30.73%33.28M

-47.87%29.07M

-43.62%36.89M

--41.71M

-58.46%48.04M

-46.23%55.76M

1422.96%65.42M

1257.98%115.66M

2289.85%103.70M

54.54%4.30M

88.82%8.52M

35.63%4.34M

-60.52%2.78M

63.33%4.51M

-36.12%3.20M

-4.47%7.04M

1289.74%2.76M

8094.84%5.01M

15661.48%7.37M

-87.78%198.73K

-98.37%61.11K

-83.39%46.76K

70.99%1.63M

394.38%3.76M

-65.56%281.49K

--951.00K

--760.36K

1402.55%817.24K

-100.00%0.00

54839.39%54.39K

-84.21%27.00

270.59%63.00

-54.17%99.00

--135.00

--171.00

--17.00

--216.00

Free cash flow

---1.90M

---17.41M

-61.56%-17.63M

----

---10.91M

----

---6.33M

----

-20.98%-4.83M

----

---3.99M

----

6.22%-2.40M

5.70%-824.60K

----

---2.56M

---874.45K

----

-54.17%-4.99K

64.22%-3.48K

----

45.90%-3.24K

-45.34%-9.74K

89.25%-236.00

---5.45K

---5.98K

---6.70K

---2.20K

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Citius Pharmaceuticals Inc Generate?



Citius Pharmaceuticals Inc generated -26.55M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Citius Pharmaceuticals Inc's Operating Cash Flow Change Year Over Year?



Citius Pharmaceuticals Inc's operating cash flow increased by 5.85% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Citius Pharmaceuticals Inc Spend on Capital Expenditures?



Citius Pharmaceuticals Inc spent 5.75M on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Citius Pharmaceuticals Inc's Financing Cash Flow Changed?



Citius Pharmaceuticals Inc used 33.30M in financing activities in the latest quarter.

What is free cash flow and why does it matter for CTXR?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Citius Pharmaceuticals Inc’s free cash flow in the latest quarter?



Free cash flow was -32.30M reflecting a 2.71% change from the previous year.